{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:02:45Z","timestamp":1740106965872,"version":"3.37.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T00:00:00Z","timestamp":1611360000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T00:00:00Z","timestamp":1611360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA040907","DA046215"],"award-info":[{"award-number":["DA040907","DA046215"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008065","name":"Georgia Research Alliance","doi-asserted-by":"crossref","award":["GRA.VL19.I1\/2"],"award-info":[{"award-number":["GRA.VL19.I1\/2"]}],"id":[{"id":"10.13039\/100008065","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s00213-021-05764-4","type":"journal-article","created":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T15:02:58Z","timestamp":1611414178000},"page":"1183-1192","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["MDPV \u201chigh-responder\u201d rats also self-administer more oxycodone than their \u201clow-responder\u201d counterparts under a fixed ratio schedule of reinforcement"],"prefix":"10.1007","volume":"238","author":[{"given":"Brenda M.","family":"Gannon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenner C.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8143-0541","authenticated-orcid":false,"given":"Kevin S.","family":"Murnane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,23]]},"reference":[{"key":"5764_CR1","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/npp.2012.204","volume":"38","author":"MH Baumann","year":"2013","unstructured":"Baumann MH, Partilla JS, Lehner KR, Thorndike EB, Hoffman AF, Holy M, Rothman RB, Goldberg SR, Lupica CR, Sitte HH, Brandt SD, Tella SR, Cozzi NV, Schindler CW (2013) Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive \u2018bath salts\u2019 products. Neuropsychopharmacology 38:552\u2013562","journal-title":"Neuropsychopharmacology"},{"key":"5764_CR2","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1056\/NEJMra1508490","volume":"374","author":"WM Compton","year":"2016","unstructured":"Compton WM, Jones CM, Baldwin GT (2016) Relationship between nonmedical prescription-opioid use and heroin use. N Engl J Med 374:154\u2013163","journal-title":"N Engl J Med"},{"key":"5764_CR3","doi-asserted-by":"publisher","unstructured":"Daza-Losada M, Rodr\u00edguez-Arias M, Aguilar MA, Mi\u00f1arro J (2008) Effect of adolescent exposure to MDMA and cocaine on acquisition and reinstatement of morphine-induce CPP. Prog Neuropsychopharmacol Biol Psych 32:701\u2013709.\u00a0https:\/\/doi.org\/10.1016\/j.pnpbp.2007.11.017","DOI":"10.1016\/j.pnpbp.2007.11.017"},{"key":"5764_CR4","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1126\/science.1099020","volume":"305","author":"V Deroche-Gamonet","year":"2004","unstructured":"Deroche-Gamonet V, Belin D, Piazza PV (2004) Evidence for addiction-like behavior in the rat. Science 305:1014\u20131017","journal-title":"Science"},{"key":"5764_CR5","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.bcp.2013.04.004","volume":"85","author":"AJ Eshleman","year":"2013","unstructured":"Eshleman AJ, Wolfrum KM, Hatfield MG, Johnson RA, Murphy KV, Janowsky A (2013) Substituted methcathinones differ in transporter and receptor interactions. Biochem Pharmacol 85:1803\u20131815","journal-title":"Biochem Pharmacol"},{"key":"5764_CR6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1124\/jpet.116.236349","volume":"360","author":"AJ Eshleman","year":"2017","unstructured":"Eshleman AJ, Wolfrum KM, Reed JF, Kim SO, Swanson T, Johnson RA, Janowsky A (2017) Structure-activity relationships of substituted cathinones, with transporter binding, uptake, and release. The Journal of pharmacology and experimental therapeutics 360:33\u201347","journal-title":"The Journal of pharmacology and experimental therapeutics"},{"key":"5764_CR7","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/npp.2012.233","volume":"38","author":"WE Fantegrossi","year":"2013","unstructured":"Fantegrossi WE, Gannon BM, Zimmerman SM, Rice KC (2013) In vivo effects of abused \u2018bath salt\u2019 constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice: drug discrimination, thermoregulation, and locomotor activity. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology 38:563\u2013573","journal-title":"Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology"},{"key":"5764_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4303\/jdar\/236009","volume":"5","author":"BM Gannon","year":"2016","unstructured":"Gannon BM, Fantegrossi WE (2016) Cocaine-like discriminative stimulus effects of mephedrone and naphyrone in mice. J Drug Alcohol Res 5:1\u20135","journal-title":"J Drug Alcohol Res"},{"key":"5764_CR9","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1124\/jpet.115.229500","volume":"356","author":"BM Gannon","year":"2016","unstructured":"Gannon BM, Williamson A, Suzuki M, Rice KC, Fantegrossi WE (2016) Stereoselective effects of abused \u201cbath salt\u201d constituent 3,4-methylenedioxypyrovalerone in mice: drug discrimination, locomotor activity, and thermoregulation. The Journal of pharmacology and experimental therapeutics 356:615\u2013623","journal-title":"The Journal of pharmacology and experimental therapeutics"},{"key":"5764_CR10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1124\/jpet.116.239376","volume":"361","author":"BM Gannon","year":"2017","unstructured":"Gannon BM, Galindo KI, Rice KC, Collins GT (2017a) Individual differences in the relative reinforcing effects of 3,4-methylenedioxypyrovalerone under fixed and progressive ratio schedules of reinforcement in rats. The Journal of pharmacology and experimental therapeutics 361:181\u2013189","journal-title":"The Journal of pharmacology and experimental therapeutics"},{"key":"5764_CR11","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1097\/FBP.0000000000000315","volume":"28","author":"BM Gannon","year":"2017","unstructured":"Gannon BM, Rice KC, Collins GT (2017b) Reinforcing effects of abused \u2018bath salts\u2019 constituents 3,4-methylenedioxypyrovalerone and \u03b1-pyrrolidinopentiophenone and their enantiomers. Behav Pharmacol 28:578\u2013581","journal-title":"Behav Pharmacol"},{"key":"5764_CR12","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.drugalcdep.2017.06.031","volume":"179","author":"BM Gannon","year":"2017","unstructured":"Gannon BM, Russell LN, Modi MS, Rice KC, Fantegrossi WE (2017c) Effects of orally self-administered bath salt constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice. Drug and alcohol dependence 179:408\u2013415","journal-title":"Drug and alcohol dependence"},{"key":"5764_CR13","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1038\/s41386-018-0209-3","volume":"43","author":"BM Gannon","year":"2018","unstructured":"Gannon BM, Baumann MH, Walther D, Jimenez-Morigosa C, Sulima A, Rice KC, Collins GT (2018a) The abuse-related effects of pyrrolidine-containing cathinones are related to their potency and selectivity to inhibit the dopamine transporter. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 43:2399\u20132407","journal-title":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology"},{"key":"5764_CR14","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/npp.2017.141","volume":"43","author":"BM Gannon","year":"2018","unstructured":"Gannon BM, Galindo KI, Mesmin MP, Rice KC, Collins GT (2018b) Reinforcing effects of binary mixtures of common bath salt constituents: studies with 3,4-methylenedioxypyrovalerone (MDPV), 3,4-methylenedioxymethcathinone (methylone), and caffeine in rats. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 43:761\u2013769","journal-title":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology"},{"key":"5764_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.neuropharm.2017.08.018","volume":"134","author":"BM Gannon","year":"2018","unstructured":"Gannon BM, Galindo KI, Mesmin MP, Sulima A, Rice KC, Collins GT (2018c) Relative reinforcing effects of second-generation synthetic cathinones: acquisition of self-administration and fixed ratio dose-response curves in rats. Neuropharmacology 134:28\u201335","journal-title":"Neuropharmacology"},{"key":"5764_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neuropharm.2017.09.004","volume":"134","author":"BM Gannon","year":"2018","unstructured":"Gannon BM, Williamson A, Rice KC, Fantegrossi WE (2018d) Role of monoaminergic systems and ambient temperature in bath salts constituent 3,4-methylenedioxypyrovalerone (MDPV)-elicited hyperthermia and locomotor stimulation in mice. Neuropharmacology 134:13\u201321","journal-title":"Neuropharmacology"},{"key":"5764_CR17","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/s00213-018-5046-x","volume":"236","author":"BM Gannon","year":"2019","unstructured":"Gannon BM, Mesmin MP, Sulima A, Rice KC, Collins GT (2019) Behavioral economic analysis of the reinforcing effects of \u201cbath salts\u201d mixtures: studies with MDPV, methylone, and caffeine in male Sprague-Dawley rats. Psychopharmacology 236:1031\u20131041","journal-title":"Psychopharmacology"},{"key":"5764_CR18","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/FBP.0b013e328364166d","volume":"24","author":"MB Gatch","year":"2013","unstructured":"Gatch MB, Taylor CM, Forster MJ (2013) Locomotor stimulant and discriminative stimulus effects of \u2018bath salt\u2019 cathinones. Behav Pharmacol 24:437\u2013447","journal-title":"Behav Pharmacol"},{"key":"5764_CR19","doi-asserted-by":"publisher","unstructured":"Guirguis A, Corkery JM, Stair JL, Kirton SB, Zloh M, Schifano F (2017) Intended and unintended use of cathinone mixtures. Hum Psychopharmacol 32.\u00a0https:\/\/doi.org\/10.1016\/j.forsciint.2017.01.027","DOI":"10.1016\/j.forsciint.2017.01.027"},{"key":"5764_CR20","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/FBP.0000000000000548","volume":"31","author":"WS Hyatt","year":"2020","unstructured":"Hyatt WS, Hirsh CE, Russell LN, Chitre NM, Murnane KS, Rice KC, Fantegrossi WE (2020) The synthetic cathinone 3,4-methylenedioxypyrovalerone increases impulsive action in rats. Behav Pharmacol. 31:309\u2013321","journal-title":"Behav Pharmacol."},{"key":"5764_CR21","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1080\/02791072.2014.962717","volume":"46","author":"PS Johnson","year":"2014","unstructured":"Johnson PS, Johnson MW (2014) Investigation of \u201cbath salts\u201d use patterns within an online sample of users in the United States. J Psychoactive Drugs 46:369\u2013378","journal-title":"J Psychoactive Drugs"},{"key":"5764_CR22","doi-asserted-by":"publisher","unstructured":"Kapitany-Foveny M, Kiss A, Farkas J, Kuczora KE, Pataki P, Horvath J, Demetrovics Z (2020) Childhood Trauma, Cognitive Emotion Regulation and Motivation for Behavior Change Among Clients of Opioid Substitution Treatment With and Without Past Year Synthetic Cathinone Use During Therapy. Front Neurosci 14:37.\u00a0https:\/\/doi.org\/10.3389\/fnins.2020.00037","DOI":"10.3389\/fnins.2020.00037"},{"key":"5764_CR23","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1146\/annurev-publhealth-031914-122957","volume":"36","author":"A Kolodny","year":"2015","unstructured":"Kolodny A, Courtwright DT, Hwang CS, Kreiner P, Eadie JL, Clark TW, Alexander GC (2015) The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annu Rev Public Health 36:559\u2013574","journal-title":"Annu Rev Public Health"},{"key":"5764_CR24","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.36076\/ppj.2008\/11\/S63","volume":"11","author":"L Manchikanti","year":"2008","unstructured":"Manchikanti L, Singh A (2008) Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician 11:S63\u2013S88","journal-title":"Pain Physician"},{"key":"5764_CR25","doi-asserted-by":"crossref","first-page":"401","DOI":"10.36076\/ppj.2010\/13\/401","volume":"13","author":"L Manchikanti","year":"2010","unstructured":"Manchikanti L, Fellows B, Ailinani H, Pampati V (2010) Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. Pain Physician 13:401\u2013435","journal-title":"Pain Physician"},{"key":"5764_CR26","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00213-017-4536-6","volume":"234","author":"M Mavrikaki","year":"2017","unstructured":"Mavrikaki M, Pravetoni M, Page S, Potter D, Chartoff E (2017) Oxycodone self-administration in male and female rats. Psychopharmacology 234:977\u2013987","journal-title":"Psychopharmacology"},{"key":"5764_CR27","unstructured":"National Research Council (2011) Guide for the care and use of laboratory animals"},{"key":"5764_CR28","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1159\/000138023","volume":"29","author":"P Nencini","year":"1984","unstructured":"Nencini P, Ahmed AM, Anania MC, Moscucci M, Paroli E (1984) Prolonged analgesia induced by cathinone. The role of stress and opioid and nonopioid mechanisms. Pharmacology 29:269\u2013281","journal-title":"Pharmacology"},{"key":"5764_CR29","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/FTD.0b013e318208b693","volume":"33","author":"IA Ojanper\u00e4","year":"2011","unstructured":"Ojanper\u00e4 IA, Heikman PK, Rasanen IJ (2011) Urine analysis of 3,4-methylenedioxypyrovalerone in opioid-dependent patients by gas chromatography-mass spectrometry. Ther Drug Monit 33:257\u2013263","journal-title":"Ther Drug Monit"},{"key":"5764_CR30","doi-asserted-by":"crossref","unstructured":"Ray A, Chitre NM, Daphney CM, Blough BE, Canal CE, Murnane KS (2018) Effects of the second-generation \u201cbath salt\u201d cathinone alpha-pyrrolidinopropiophenone (alpha-PPP) on behavior and monoamine neurochemistry in male mice. Psychopharmacology","DOI":"10.1007\/s00213-018-5044-z"},{"key":"5764_CR31","doi-asserted-by":"publisher","first-page":"art235991","DOI":"10.4303\/jdar\/235991","volume":"5","author":"H Rosas-Hernandez","year":"2016","unstructured":"Rosas-Hernandez H, Cuevas E, Lantz SM, Imam SZ, Rice KC, Gannon BM, Fantegrossi WE, Paule MG, Ali SF (2016a) 3,4-methylenedioxypyrovalerone (MDPV) induces cytotoxic effects on human dopaminergic SH-SY5Y cells. J Drug Alcohol Res 5:art235991","journal-title":"J Drug Alcohol Res"},{"key":"5764_CR32","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.neulet.2016.06.029","volume":"629","author":"H Rosas-Hernandez","year":"2016","unstructured":"Rosas-Hernandez H, Cuevas E, Lantz SM, Rice KC, Gannon BM, Fantegrossi WE, Gonzalez C, Paule MG, Ali SF (2016b) Methamphetamine, 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxypyrovalerone (MDPV) induce differential cytotoxic effects in bovine brain microvessel endothelial cells. Neuroscience letters 629:125\u2013130","journal-title":"Neuroscience letters"},{"key":"5764_CR33","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1007\/s00213-015-4057-0","volume":"233","author":"CW Schindler","year":"2016","unstructured":"Schindler CW, Thorndike EB, Goldberg SR, Lehner KR, Cozzi NV, Brandt SD, Baumann MH (2016) Reinforcing and neurochemical effects of the \u201cbath salts\u201d constituents 3,4-methylenedioxypyrovalerone (MDPV) and 3,4-methylenedioxy-N-methylcathinone (methylone) in male rats. Psychopharmacology 233:1981\u20131990","journal-title":"Psychopharmacology"},{"key":"5764_CR34","doi-asserted-by":"publisher","unstructured":"Shapira B, Berkovitz R, Rosca P, Neumark Y (2020) Recent Use of Synthetic Cannabinoids, Synthetic Opioids, and Other Psychoactive Drug Groups among High-risk Drug Users. J Psychoactive Drugs 1-10.\u00a0https:\/\/doi.org\/10.1080\/02791072.2020.1754534","DOI":"10.1080\/02791072.2020.1754534"},{"key":"5764_CR35","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1476-5381.2012.02145.x","volume":"168","author":"LD Simmler","year":"2013","unstructured":"Simmler LD, Buser TA, Donzelli M, Schramm Y, Dieu LH, Huwyler J, Chaboz S, Hoener MC, Liechti ME (2013) Pharmacological characterization of designer cathinones in vitro. Br J Pharmacol 168:458\u2013470","journal-title":"Br J Pharmacol"},{"key":"5764_CR36","unstructured":"United Nations Office on Drugs and Crime (2018) Analysis of drug markets: opiates, cocaine, cannabis, synthetic drugs. World Drug Report"},{"key":"5764_CR37","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/npp.2014.188","volume":"40","author":"CL Wade","year":"2015","unstructured":"Wade CL, Vendruscolo LF, Schlosburg JE, Hernandez DO, Koob GF (2015) Compulsive-like responding for opioid analgesics in rats with extended access. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 40:421\u2013428","journal-title":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology"},{"key":"5764_CR38","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1111\/j.1360-0443.2011.03502.x","volume":"106","author":"A Winstock","year":"2011","unstructured":"Winstock A, Mitcheson L, Ramsey J, Davies S, Puchnarewicz M, Marsden J (2011) Mephedrone: use, subjective effects and health risks. Addiction 106:1991\u20131996","journal-title":"Addiction"},{"key":"5764_CR39","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.neuropharm.2017.09.007","volume":"126","author":"ZB You","year":"2017","unstructured":"You ZB, Gao JT, Bi GH, He Y, Boateng C, Cao J, Gardner EL, Newman AH, Xi ZX (2017) The novel dopamine D3 receptor antagonists\/partial agonists CAB2-015 and BAK4-54 inhibit oxycodone-taking and oxycodone-seeking behavior in rats. Neuropharmacology 126:190\u2013199","journal-title":"Neuropharmacology"},{"key":"5764_CR40","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41386-018-0284-5","volume":"44","author":"ZB You","year":"2019","unstructured":"You ZB, Bi GH, Galaj E, Kumar V, Cao J, Gadiano A, Rais R, Slusher BS, Gardner EL, Xi ZX, Newman AH (2019) Dopamine D(3)R antagonist VK4-116 attenuates oxycodone self-administration and reinstatement without compromising its antinociceptive effects. Neuropsychopharmacology 44:1415\u20131424","journal-title":"Neuropsychopharmacology"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-021-05764-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-021-05764-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-021-05764-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T03:57:01Z","timestamp":1618977421000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-021-05764-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,23]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["5764"],"URL":"https:\/\/doi.org\/10.1007\/s00213-021-05764-4","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"type":"print","value":"0033-3158"},{"type":"electronic","value":"1432-2072"}],"subject":[],"published":{"date-parts":[[2021,1,23]]},"assertion":[{"value":"2 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}